Skip to main content
Toggle navigation
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Full Schedule
Home
Full Schedule
All Days
Wed, Oct 18
Thu, Oct 19
Fri, Oct 20
Sat, Oct 21
Full Schedule
Type here to filter the list
Saturday, October 21, 2023
7:00 AM – 8:00 AM
ET
Exhibit Hall
7:00 AM – 8:00 AM
ET
Exhibit Hall Break
Location: Metropolitan West
7:30 AM – 9:15 AM
ET
Session XIII: BTKi as a Target
Moderator:
Richard R. Furman, MD
– NewYork Presbyterian Hospital, Weill Cornell Medicine
Presenter:
John N. Allan, MD
– Weill Cornell Medicine
Presenter:
Nicole Lamanna, MD
– Columbia University Medical Center/New York Presbyterian
Presenter:
Susan O’Brien, MD
– University of California Irvine
7:30 AM – 9:15 AM
ET
Session XIII: BTKi as a Target
Location: Metropolitan East
Moderator:
Richard R. Furman, MD
– NewYork Presbyterian Hospital, Weill Cornell Medicine
Presenter:
John N. Allan, MD
– Weill Cornell Medicine
Presenter:
Nicole Lamanna, MD
– Columbia University Medical Center/New York Presbyterian
Presenter:
Susan O’Brien, MD
– University of California Irvine
7:30 AM – 7:35 AM
ET
Welcome and Introduction: Chronic Lymphocytic Leukemia Session
Location: Metropolitan East
7:35 AM – 7:40 AM
ET
Pre-Session Audience Survey
Location: Metropolitan East
7:40 AM – 8:00 AM
ET
Ibrutinib and CAPTIVATE Data Updates
Location: Metropolitan East
Speaker:
John N. Allan, MD
– Weill Cornell Medicine
8:00 AM – 8:20 AM
ET
Acalabrutinib Data Updates
Location: Metropolitan East
Speaker:
Richard R. Furman, MD
– NewYork Presbyterian Hospital, Weill Cornell Medicine
8:20 AM – 8:40 AM
ET
Zanubrutinib Data Updates
Location: Metropolitan East
Speaker:
Susan O’Brien, MD
– University of California Irvine
8:40 AM – 9:00 AM
ET
Pirtobrutinib: The New Kid on the Block
Location: Metropolitan East
Speaker:
Nicole Lamanna, MD
– Columbia University Medical Center/New York Presbyterian
9:00 AM – 9:15 AM
ET
Panel Discussion: BTKi: Compare and Contrast Efficacy and Toxicity and Post-Session Audience Survey
Location: Metropolitan East
Moderator:
Richard R. Furman, MD
– NewYork Presbyterian Hospital, Weill Cornell Medicine
Panelist:
John N. Allan, MD
– Weill Cornell Medicine
Panelist:
Nicole Lamanna, MD
– Columbia University Medical Center/New York Presbyterian
Panelist:
Susan O’Brien, MD
– University of California Irvine
8:00 AM – 9:30 AM
ET
Spanish Session Myeloma
Moderator:
Ruben Niesvizky, MD
– Weill Cornell Medicine/NewYork-Presbyterian Hospital
Panelist:
María-Victoria Mateos, PhD
– University Hospital of Salamanca
Panelist:
Jorge Monge, MD
– Weill Cornell Medicine
Spanish Session
8:00 AM – 9:30 AM
ET
Spanish Session Myeloma
Location: Lenox Ballroom
Moderator:
Ruben Niesvizky, MD
– Weill Cornell Medicine/NewYork-Presbyterian Hospital
Panelist:
María-Victoria Mateos, PhD
– University Hospital of Salamanca
Panelist:
Jorge Monge, MD
– Weill Cornell Medicine
Spanish Session
9:00 AM – 10:00 AM
ET
Exhibit Hall
9:00 AM – 10:00 AM
ET
Exhibit Hall Break
Location: Metropolitan West
9:45 AM – 11:20 AM
ET
Session XIV: BCL2 as Target
Moderator:
Matthew S. Davids, MD, MMSc
– Dana-Farber Cancer Institute / Harvard Medical School
Presenter:
Othman Al-Sawaf, MD
– University Hospital of Cologne
Presenter:
Javier Pinilla Ibarz, MD, PhD
– Moffitt Cancer Center
Presenter:
Asher Chanan-Khan, MD
– Mayo Clinic
9:45 AM – 11:20 AM
ET
Session XIV: BCL2 as Target
Location: Metropolitan East
Moderator:
Matthew S. Davids, MD, MMSc
– Dana-Farber Cancer Institute / Harvard Medical School
Presenter:
Othman Al-Sawaf, MD
– University Hospital of Cologne
Presenter:
Javier Pinilla Ibarz, MD, PhD
– Moffitt Cancer Center
Presenter:
Asher Chanan-Khan, MD
– Mayo Clinic
9:45 AM – 9:50 AM
ET
Welcome
Location: Metropolitan East
9:50 AM – 10:10 AM
ET
The Prince Family Lecture: BCL2 in CLL: Function, Targeting, and Resistance
Location: Metropolitan East
Speaker:
Matthew S. Davids, MD, MMSc
– Dana-Farber Cancer Institute / Harvard Medical School
10:10 AM – 10:30 AM
ET
Venetoclax: What is the Optimal Duration of Treatment? What is the Role of MRD in Determining Duration?
Location: Metropolitan East
Speaker:
Othman Al-Sawaf, MD
– University Hospital of Cologne
10:30 AM – 10:45 AM
ET
Debate: BTKi vs BCL2i: Round 2 - BTKi
Location: Metropolitan East
Debate Speaker:
Javier Pinilla Ibarz, MD, PhD
– Moffitt Cancer Center
10:45 AM – 11:00 AM
ET
Debate: BTKi vs BCL2i: Round 2 - BCL2i
Location: Metropolitan East
Debate Speaker:
Asher Chanan-Khan, MD
– Mayo Clinic
11:00 AM – 11:20 AM
ET
Panel Discussion
Location: Metropolitan East
Moderator:
Matthew S. Davids, MD, MMSc
– Dana-Farber Cancer Institute / Harvard Medical School
Panelist:
Othman Al-Sawaf, MD
– University Hospital of Cologne
Panelist:
Asher Chanan-Khan, MD
– Mayo Clinic
Panelist:
Matthew S. Davids, MD, MMSc
– Dana-Farber Cancer Institute / Harvard Medical School
Panelist:
Javier Pinilla Ibarz, MD, PhD
– Moffitt Cancer Center
11:20 AM – 1:20 PM
ET
Session XV: What, When and How to Use our New Armamentarium
Moderator:
Richard R. Furman, MD
– NewYork Presbyterian Hospital, Weill Cornell Medicine
Presenter:
John N. Allan, MD
– Weill Cornell Medicine
Presenter:
Matthew S. Davids, MD, MMSc
– Dana-Farber Cancer Institute / Harvard Medical School
Presenter:
Richard R. Furman, MD
– NewYork Presbyterian Hospital, Weill Cornell Medicine
Presenter:
Neil E. Kay, MD
– Mayo Clinic
11:20 AM – 1:20 PM
ET
Session XV: What, When and How to Use our New Armamentarium
Location: Metropolitan East
Moderator:
Richard R. Furman, MD
– NewYork Presbyterian Hospital, Weill Cornell Medicine
Presenter:
John N. Allan, MD
– Weill Cornell Medicine
Presenter:
Matthew S. Davids, MD, MMSc
– Dana-Farber Cancer Institute / Harvard Medical School
Presenter:
Richard R. Furman, MD
– NewYork Presbyterian Hospital, Weill Cornell Medicine
Presenter:
Neil E. Kay, MD
– Mayo Clinic
11:20 AM – 11:25 AM
ET
Welcome
Location: Metropolitan East
11:25 AM – 11:50 AM
ET
Rai Lecture: The Biology and Management of Double Refractory CLL
Location: Metropolitan East
Speaker:
Neil E. Kay, MD
– Mayo Clinic
11:50 AM – 12:10 PM
ET
Where are Bispecifics in CLL
Location: Metropolitan East
Speaker:
John N. Allan, MD
– Weill Cornell Medicine
12:10 PM – 12:35 PM
ET
Next Gen Therapies
Location: Metropolitan East
Speaker:
Richard R. Furman, MD
– NewYork Presbyterian Hospital, Weill Cornell Medicine
12:35 PM – 1:00 PM
ET
Management of Richter’s Transformation
Location: Metropolitan East
Speaker:
Matthew S. Davids, MD, MMSc
– Dana-Farber Cancer Institute / Harvard Medical School
1:00 PM – 1:20 PM
ET
Panel Discussion
Location: Metropolitan East
Panelist:
John N. Allan, MD
– Weill Cornell Medicine
Panelist:
Neil E. Kay, MD
– Mayo Clinic
Panelist:
Richard R. Furman, MD
– NewYork Presbyterian Hospital, Weill Cornell Medicine
Panelist:
Matthew S. Davids, MD, MMSc
– Dana-Farber Cancer Institute / Harvard Medical School
1:20 PM – 2:35 PM
ET
Non-CME Innovation Theater - Lunch
1:20 PM – 2:35 PM
ET
Non-CME Innovation Theater - Lunch (Sponsored by Abbvie US Medical Affairs)
Location: Empire West
Innovation Theater
1:20 PM – 2:35 PM
ET
Non-CME Innovation Theater - Lunch (Sponsored by AstraZeneca)
Location: Empire East
Innovation Theater
2:35 PM – 3:15 PM
ET
Session XVI: Case Discussions in CLL
Moderator:
Richard R. Furman, MD
– NewYork Presbyterian Hospital, Weill Cornell Medicine
Presenter:
John N. Allan, MD
– Weill Cornell Medicine
Presenter:
Matthew S. Davids, MD, MMSc
– Dana-Farber Cancer Institute / Harvard Medical School
Presenter:
Neil E. Kay, MD
– Mayo Clinic
2:35 PM – 3:15 PM
ET
Session XVI: Case Discussions in CLL
Location: Metropolitan East
Moderator:
Richard R. Furman, MD
– NewYork Presbyterian Hospital, Weill Cornell Medicine
Presenter:
John N. Allan, MD
– Weill Cornell Medicine
Presenter:
Matthew S. Davids, MD, MMSc
– Dana-Farber Cancer Institute / Harvard Medical School
Presenter:
Neil E. Kay, MD
– Mayo Clinic
2:35 PM – 3:15 PM
ET
Case Discussions in CLL
Location: Metropolitan East
Moderator:
Richard R. Furman, MD
– NewYork Presbyterian Hospital, Weill Cornell Medicine
Panelist:
John N. Allan, MD
– Weill Cornell Medicine
Panelist:
Matthew S. Davids, MD, MMSc
– Dana-Farber Cancer Institute / Harvard Medical School
Panelist:
Neil E. Kay, MD
– Mayo Clinic
